The Effect of Exenatide on Insulin Requirement, Weight and Inflammation in Obese Type 2 Diabetic Subjects on Insulin.
Phase of Trial: Phase II
Latest Information Update: 14 Dec 2012
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 14 Dec 2012 Actual end date Nov 2011 added as reported by ClinicalTrials.gov.
- 05 Jun 2012 Planned End Date changed from 1 May 2011 to 1 May 2013 as reported by ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History